NEW YORK, May 7 – Orchid BioSciences announced today approval from the American Association of Blood Banks to use single nucleotide polymorphisms as stand-alone geneitic markers in its paternity testing operations.

 

Orchid is replacing conventional short tandem repeat technology with its SNP genotyping technology in its paternity testing operations. 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.